Impact Capital Partners’s Pfizer PFE Stock Holding History

Impact Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$330K	Sell	11,566 -608	-5%	-$16.2K	0.09%	197
2026 Q2	$293K	Sell	12,174 -552	-4%	-$14.4K	0.08%	218
2026 Q1	$357K	Buy	12,726 +970	+8%	+$25.8K	0.11%	184
2025 Q4	$293K	Sell	11,756 -1,177	-9%	-$29.7K	0.09%	223
2025 Q3	$330K	Buy	12,933 +629	+5%	+$15.5K	0.1%	195
2025 Q2	$298K	Sell	12,304 -1,382	-10%	-$32.2K	0.1%	204
2025 Q1	$347K	Buy	13,686 +2,864	+26%	+$74.9K	0.13%	183
2024 Q4	$287K	Buy	+10,822	New	+$294K	0.1%	209

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Impact Capital Partners's PFE Position: Q3 2026 in Review

Impact Capital Partners reduced its Pfizer (PFE) stake by 5% in Q3 2026, selling an estimated $16.2K and leaving 11,566 shares worth $330K. The position accounts for 0.09% of the portfolio, ranked #197.

Impact Capital Partners first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. The position peaked at $357K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

Impact Capital Partners held 11,566 shares of Pfizer worth $330K as of Q3 2026.
Impact Capital Partners sold 608 Pfizer shares in Q3 2026, an estimated $16.2K.
Pfizer made up 0.09% of Impact Capital Partners's portfolio in Q3 2026, its #197 holding.
Impact Capital Partners first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
Impact Capital Partners's Pfizer position peaked at $357K in Q1 2026.
1,037 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Impact Capital Partners's 13F filing for Q3 2026, filed 22 Oct 2026.